GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012

被引:0
|
作者
A. González Martín
A. Redondo
M. Jurado
A. De Juan
I. Romero
I. Bover
J. M. Del Campo
A. Cervantes
Y. García
J. A. López-Guerrero
C. Mendiola
J. Palacios
M. J. Rubio
A. Poveda Velasco
机构
[1] MD Anderson Cancer Center,Medical Oncology Department
[2] University Hospital La Paz,Medical Oncology Department
[3] University of Navarra,Department of Gynecology, School of Medicine
[4] University Hospital Marqués de Valdecilla,Department of Medical Oncology
[5] Department of Medical Oncology,Medical Oncology Department
[6] Fundación Instituto Valenciano de Oncología,Department of Medical Oncology
[7] Hospital Son Llàtzer,Department of Hematology and Medical Oncology, Institute of Health Research INCLIVA
[8] Vall d’Hebron University Hospital,Department of Medical Oncology
[9] Hospital Clínico Universitario,Laboratory of Molecular Biology
[10] University of Valencia,Medical Oncology Department
[11] Sabadell Hospital,Department of Pathology
[12] Parc Taulí Healthcare Corporation,Department of Medical Oncology
[13] Fundación Instituto Valenciano de Oncología,Department of Medical Oncology
[14] University Hospital 12 de Octubre,undefined
[15] University Hospital Ramón y Cajal,undefined
[16] University Hospital Reina Sofía,undefined
[17] Fundación Instituto Valenciano de Oncología,undefined
来源
关键词
Ovarian cancer; Treatment guidelines; Chemotherapy; Surgery; First line; Recurrent disease;
D O I
暂无
中图分类号
学科分类号
摘要
In 2006, under the auspices of The Spanish Research Group for Ovarian Cancer (Spanish initials GEICO), the first “Treatment Guidelines in Ovarian Cancer” were developed and then published in Clinical and Translational Oncology by Poveda Velasco et al. (Clin Transl Oncol 9(5):308–316, 2007). Almost 6 years have elapsed and over this time, we have seen some important developments in the treatment of ovarian cancer. Significant changes were also introduced after the GCIG-sponsored 4th Consensus Conference on Ovarian Cancer by Stuart et al. (Int J Gynecol Cancer 21:750–755, 2011). So we decided to update the treatment guidelines in ovarian cancer and, with this objective, a group of investigators of the GEICO group met in February 2012. This study summarizes the presentations, discussions and evidence that were reviewed during the meeting and during further discussions of the manuscript.
引用
收藏
页码:509 / 525
页数:16
相关论文
共 50 条
  • [1] GEICO (Spanish Group for Investigation on Ovarian Cancer) treatment guidelines in ovarian cancer 2012
    Gonzalez Martin, A.
    Redondo, A.
    Jurado, M.
    De Juan, A.
    Romero, I.
    Bover, I.
    Del Campo, J. M.
    Cervantes, A.
    Garcia, Y.
    Lopez-Guerrero, J. A.
    Mendiola, C.
    Palacios, J.
    Rubio, M. J.
    Poveda Velasco, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2013, 15 (07): : 509 - 525
  • [2] ROSE study: A retrospective evaluation of clinical management of advanced ovarian cancer (AOC) in Spain by the Spanish Group for Research in Ovarian Cancer (GEICO)
    Girones, R.
    Alonso, J. L.
    Arcusa, A.
    Sanchez, A. B.
    Barretina, P.
    Borrega, P.
    Cueva, J.
    Alarcon, J. D.
    Esteban, M. C.
    Fuentes, J.
    Garcia, A.
    Garrigos, L.
    Guerra, E.
    Herrero, A.
    Lainez, N.
    Maximiano, C.
    Martinez, P.
    Gonzalez-Martin, A.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S556 - S556
  • [3] Prolonged infusion of gemcitabine in patients with platinum resistant or refractory recurrent ovarian carcinoma:: A phase II study Of GEICO (Spanish Group for investigation on ovarian cancer).
    Ojeda, B
    Gonzaléz-Martín, A
    Mellado, B
    Bover, I
    Fabregat, X
    Rubio, MJ
    Alonso, L
    Lianes, P
    Churruca, C
    Poveda, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 479S - 479S
  • [4] Early stages (I-IIa) epithelial ovarian cancer (EOC): Preliminary data of the prospective register of the Spanish Group on Research of Ovarian cancer (GEICO)
    Ojeda, B.
    Poveda, A.
    Herrero, A.
    del Campo, J. M.
    Casado, A.
    Alvarez, I.
    Churruca, C.
    Pelegri, A.
    Santaolalla, A.
    Godes, M. J.
    ANNALS OF ONCOLOGY, 2004, 15 : 132 - 133
  • [5] EARLY STAGES (I-IIA) EPITHELIAL OVARIAN CANCER (EOC): PRELIMINARY DATA OF THE PROSPECTIVE REGISTER OF THE SPANISH GROUP ON RESEARCH OF OVARIAN CANCER (GEICO)
    Ruiz, N.
    del Campo, J. M.
    Calvo, E.
    Santaballa, A.
    Churruca, C.
    Herrero, A.
    Casado, A.
    Lainez, N.
    Poveda, A.
    Ojeda, B.
    ANNALS OF ONCOLOGY, 2008, 19 : 212 - 212
  • [6] Treatment guidelines in ovarian cancer
    A. Poveda Velasco
    A. Casado Herráez
    A. Cervantes Ruipérez
    D. Gallardo Rincón
    E. García García
    A. González Martín
    G. López García
    C. Mendiola Fernández
    B. Ojeda González
    Clinical and Translational Oncology, 2007, 9 : 308 - 316
  • [7] Treatment guidelines in ovarian cancer
    Velasco, A. Poveda
    Herraez, A. Casado
    Ruiperez, A. Cervantes
    Rincon, D. Gallardo
    Garcia, E. Garcia
    Martin, A. Gonzalez
    Garcia, G. Lopez
    Fernandez, C. Mendiola
    Gonzalez, B. Ojeda
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (05): : 308 - 316
  • [8] Clinicopathological Significance of Taz and VGLL1 Expression in Early Stage Ovarian Cancer. A study by Spanish Group for Ovarian Cancer Research (GEICO).
    Antonio Lopez-Guerrero, Jose
    Gutierrez Pecharroman, Ana
    Palacios, Jose
    Cristobal Lana, Eva Maria
    Romero, Ignacio
    Hardisson, David
    Vera-Sempere, Francisco
    Illueca, Carmen
    Vieites, Begoaa
    Garcia, Angel
    Ibarra de la Rosa, Javier
    Alonso, Sofia Hakin
    Guarch Troyas, Rosa
    Andrada, Encarna
    Montes, Santiago
    Pastor, Francisco
    Carmen Gomez, Maria
    Amparo Torroba, Maria
    D'Angelo, Emanuela
    Poveda, Andres
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Mismatch Repair (MMR) Protein Deficiency in Early Stage Ovarian Carcinomas. A Study by Spanish Ovarian Cancer Research Group (GEICO)
    Palacios, Jose
    Gutierrez-Pecharroman, Ana
    Cristobal, Eva
    Antonio Lopez-Guerrero, Jose
    Romero, Ignacio
    Hardisson, David
    Vera, Francisco
    Vieites, Begona
    Garcia, Angel
    Ibarra, Javier
    Hakin, Sofia
    Guarch, Rosa
    Andrada, Encarna
    Montes, Santiago
    Pastor, Francisco
    Gomez, Maria C.
    Gomez, Maria C.
    Poveda, Andres
    LABORATORY INVESTIGATION, 2016, 96 : 301A - 301A
  • [10] Mismatch Repair (MMR) Protein Deficiency in Early Stage Ovarian Carcinomas. A Study by Spanish Ovarian Cancer Research Group (GEICO)
    Palacios, Jose
    Gutierrez-Pecharroman, Ana
    Cristobal, Eva
    Antonio Lopez-Guerrero, Jose
    Romero, Ignacio
    Hardisson, David
    Vera, Francisco
    Vieites, Begona
    Garcia, Angel
    Lbarra, Javier
    Hakin, Sofia
    Guarch, Rosa
    Andrada, Encarna
    Montes, Santiago
    Pastor, Francisco
    Gomez, Maria C.
    Gomez, Maria C.
    Poveda, Andres
    MODERN PATHOLOGY, 2016, 29 : 301A - 301A